Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
166.96+8.81 (+5.57%)
At close: 04:00PM EDT
167.75 +0.79 (+0.47%)
After hours: 07:31PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close158.15
Open159.88
Bid165.00 x 1000
Ask167.88 x 800
Day's Range157.77 - 167.68
52 Week Range121.32 - 464.00
Volume1,069,952
Avg. Volume1,549,190
Market Cap40.574B
Beta (5Y Monthly)-0.28
PE Ratio (TTM)3.15
EPS (TTM)53.01
Earnings DateAug 08, 2022
Forward Dividend & Yield2.11 (1.26%)
Ex-Dividend DateJun 02, 2022
1y Target Est263.78
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BNTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioNTech SE
    Analyst Report: BioNTech SEBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
    Rating
    Fair Value
    Economic Moat
    19 days agoMorningstar
View more
Advertisement
Advertisement